{"id":9118,"date":"2026-06-01T22:13:44","date_gmt":"2026-06-01T19:13:44","guid":{"rendered":"https:\/\/gundexia.com\/?p=9118"},"modified":"2026-06-01T22:13:47","modified_gmt":"2026-06-01T19:13:47","slug":"kongodaki-ebola-salgini-neden-kontrol-altina-alinamiyor-dsoden-kritik-aciklama","status":"publish","type":"post","link":"https:\/\/gundexia.com\/?p=9118","title":{"rendered":"Kongo&#8217;daki Ebola Salg\u0131n\u0131 Neden Kontrol Alt\u0131na Al\u0131nam\u0131yor? DS\u00d6&#8217;den Kritik A\u00e7\u0131klama"},"content":{"rendered":"\n<p>D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6), Kongo Demokratik Cumhuriyeti&#8217;nde (KDC) y\u00fczlerce ki\u015finin \u00f6l\u00fcm\u00fcne yol a\u00e7an yeni Ebola salg\u0131n\u0131n\u0131n kontrolden \u00e7\u0131kma riski ta\u015f\u0131d\u0131\u011f\u0131 konusunda uyard\u0131.<\/p>\n\n\n\n<p>B\u00f6lgedeki t\u0131bbi m\u00fcdahale kapasitesini a\u015fan salg\u0131n\u0131 masaya yat\u0131rmak \u00fczere uzmanlar acil olarak bir araya geldi. Salg\u0131n\u0131n kontrol alt\u0131na al\u0131namamas\u0131n\u0131n arkas\u0131nda ise vir\u00fcs\u00fcn nadir g\u00f6r\u00fclen yap\u0131s\u0131 ve spesifik bir tedavi y\u00f6nteminin bulunmamas\u0131 yat\u0131yor.<\/p>\n\n\n\n<p><strong>Salg\u0131n\u0131n Nedeni Nadir G\u00f6r\u00fclen &#8220;Bundibugyo&#8221; Su\u015fu<\/strong><\/p>\n\n\n\n<p>Sa\u011fl\u0131k uzmanlar\u0131n\u0131 alarma ge\u00e7iren en b\u00fcy\u00fck etken, salg\u0131na neden olan vir\u00fcs\u00fcn en yayg\u0131n t\u00fcrler (Zaire veya Sudan) de\u011fil, \u00e7ok daha nadir g\u00f6r\u00fclen &#8220;Bundibugyo&#8221; vir\u00fcs\u00fc olmas\u0131. \u0130lk kez 2007 y\u0131l\u0131nda tan\u0131mlanan bu su\u015f, t\u0131p d\u00fcnyas\u0131nda az say\u0131da salg\u0131nla kayda ge\u00e7ti\u011fi i\u00e7in hakk\u0131nda yeterli klinik veri bulunmuyor.<\/p>\n\n\n\n<p>DS\u00d6 Genel Direkt\u00f6r\u00fc Dr. Tedros Adhanom Ghebreyesus, Kongo halk\u0131na hitaben yazd\u0131\u011f\u0131 a\u00e7\u0131k mektupta durumun ciddiyetini \u015fu s\u00f6zlerle ifade etti: \u201cDurum ciddi ve bunu size a\u00e7\u0131k\u00e7a s\u00f6ylemeyi hak ediyorsunuz. Bundibugyo i\u00e7in spesifik bir tedavi bulunmamakla birlikte, bu vir\u00fcs\u00fcn yay\u0131lmas\u0131n\u0131 \u00f6nlemek ve hayat kurtarmak i\u00e7in birlikte yapabilece\u011fimiz \u00e7ok \u015fey var.\u201d<\/p>\n\n\n\n<p><strong>Te\u015fhis Neden Gecikiyor ve Vir\u00fcs Nas\u0131l Bula\u015f\u0131yor?<\/strong><\/p>\n\n\n\n<p>Hastal\u0131\u011f\u0131n kontrol alt\u0131na al\u0131nmas\u0131n\u0131 zorla\u015ft\u0131ran temel fakt\u00f6rler \u015funlar:<\/p>\n\n\n\n<p><strong>Belirtilerin Maskelenmesi:<\/strong> Vir\u00fcs\u00fcn 2 ila 21 g\u00fcn aras\u0131nda de\u011fi\u015fen bir kulu\u00e7ka s\u00fcresi var. \u0130lk ortaya \u00e7\u0131kan semptomlar; ate\u015f, yorgunluk, kas, ba\u015f ve bo\u011faz a\u011fr\u0131s\u0131 gibi grip veya s\u0131tma ile kar\u0131\u015ft\u0131r\u0131labilecek s\u0131radan \u015fikayetler oldu\u011fu i\u00e7in erken tan\u0131 koymak neredeyse imkans\u0131z hale geliyor.<\/p>\n\n\n\n<p><strong>Bula\u015f Yolu ve Sa\u011fl\u0131k \u00c7al\u0131\u015fanlar\u0131:<\/strong> Vir\u00fcs; hasta veya hayat\u0131n\u0131 kaybetmi\u015f ki\u015filerin ter, kan, d\u0131\u015fk\u0131 ya da kusmuk gibi v\u00fccut s\u0131v\u0131lar\u0131yla yak\u0131n temas yoluyla bula\u015f\u0131yor.<br>Bu durum, sahada \u00e7al\u0131\u015fan sa\u011fl\u0131k personelini do\u011frudan y\u00fcksek risk grubuna sokuyor.<\/p>\n\n\n\n<p><strong>Y\u00fcksek \u00d6l\u00fcm Oran\u0131:<\/strong> Ge\u00e7mi\u015fte Uganda ve KDC&#8217;de g\u00f6r\u00fclen Bundibugyo<br>salg\u0131nlar\u0131nda \u00f6l\u00fcm oranlar\u0131n\u0131n y\u00fczde 30 ile y\u00fczde 50 aras\u0131nda seyretmesi tehlikenin boyutunu g\u00f6zler \u00f6n\u00fcne seriyor.<\/p>\n\n\n\n<p><strong>Onayl\u0131 Bir Tedavi veya A\u015f\u0131 Yok: G\u00f6zler Klinik Deneylerde<\/strong><\/p>\n\n\n\n<p>\u015eu an i\u00e7in Bundibugyo su\u015funa kar\u015f\u0131 resmi olarak lisanslanm\u0131\u015f hi\u00e7bir ila\u00e7 ya da a\u015f\u0131 bulunmuyor. Ancak DS\u00d6, umut vadeden baz\u0131 aday \u00fcr\u00fcnlerin klinik deneylerde denenmesi i\u00e7in KDC ve Uganda h\u00fck\u00fcmetleriyle ortak bir \u00e7al\u0131\u015fma y\u00fcr\u00fct\u00fcyor.<\/p>\n\n\n\n<p>Ba\u011f\u0131ms\u0131z uzmanlar taraf\u0131ndan \u00f6nceliklendirilmesi \u00f6nerilen \u00fc\u00e7 temel tedavi y\u00f6ntemi bulunuyor: Mapp Biopharmaceutical ve Regeneron firmalar\u0131n\u0131n geli\u015ftirdi\u011fi antikor tedavileri ile Gilead Sciences\u2019a ait antiviral bir ila\u00e7 olan remdesivir.<\/p>\n\n\n\n<p>Mapp firmas\u0131n\u0131n antikor tedavisi aslen Sudan vir\u00fcs\u00fc i\u00e7in tasarlanm\u0131\u015f olsa da Bundibugyo&#8217;ya kar\u015f\u0131 da koruma sa\u011flama potansiyeli ta\u015f\u0131yor.<\/p>\n\n\n\n<p><a href=\"https:\/\/gazeteoksijen.com\/saglik\/kongodaki-ebola-salgini-neden-kontrol-altina-alinamiyor-277218\">https:\/\/gazeteoksijen.com\/saglik\/kongodaki-ebola-salgini-neden-kontrol-altina-alinamiyor-277218<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6), Kongo Demokratik Cumhuriyeti&#8217;nde (KDC) y\u00fczlerce ki\u015finin \u00f6l\u00fcm\u00fcne yol a\u00e7an yeni Ebola salg\u0131n\u0131n\u0131n kontrolden \u00e7\u0131kma riski ta\u015f\u0131d\u0131\u011f\u0131 konusunda uyard\u0131. B\u00f6lgedeki t\u0131bbi m\u00fcdahale kapasitesini a\u015fan salg\u0131n\u0131 masaya yat\u0131rmak \u00fczere uzmanlar acil olarak bir araya geldi. Salg\u0131n\u0131n kontrol alt\u0131na al\u0131namamas\u0131n\u0131n arkas\u0131nda ise vir\u00fcs\u00fcn nadir g\u00f6r\u00fclen yap\u0131s\u0131 ve spesifik bir tedavi y\u00f6nteminin bulunmamas\u0131 yat\u0131yor. Salg\u0131n\u0131n [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":9119,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-9118","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"jetpack_featured_media_url":"https:\/\/gundexia.com\/wp-content\/uploads\/2026\/06\/IMG_6308.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/posts\/9118","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/gundexia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9118"}],"version-history":[{"count":1,"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/posts\/9118\/revisions"}],"predecessor-version":[{"id":9120,"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/posts\/9118\/revisions\/9120"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gundexia.com\/index.php?rest_route=\/wp\/v2\/media\/9119"}],"wp:attachment":[{"href":"https:\/\/gundexia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gundexia.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gundexia.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}